loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of chemical intermediates, fine chemicals supplied/manufactured by Ice Pharma

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Bile acid (1)

02 Cholic acid (1)

03 Lithocholic acid (1)

04 N-Acetyl-D-Mannosamine (1)

filter

01 Cholic Acid (1)

02 N-Acetyl-D-neuraminate (1)

03 Ursodeoxycholic Acid (2)

filter

01 41945-48-6 (1)

02 434-13-9 (1)

03 6282-60-6 (1)

04 7772-94-3 (1)

URL Supplier Web Content
41945-48-6
Cholic Acid
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
URL Supplier Web Content
6282-60-6
Ursodeoxycholic Acid
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
URL Supplier Web Content
434-13-9
Ursodeoxycholic Acid
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
URL Supplier Web Content
7772-94-3
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
Post Enquiry
POST ENQUIRY